Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast

被引:0
作者
Scott Kizy
Jing Li Huang
Schelomo Marmor
Todd M. Tuttle
Jane Yuet Ching Hui
机构
[1] University of Minnesota,Department of Surgery
来源
Breast Cancer Research and Treatment | 2017年 / 165卷
关键词
Breast cancer; Recurrence score; Oncotype DX; Invasive lobular carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:757 / 763
页数:6
相关论文
共 61 条
[1]  
Paik S(2004)A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817-2826
[2]  
Shak S(2015)Multigene prognostic tests in breast cancer: past, present, future Breast Cancer Res Treat 17 11-1683
[3]  
Tang G(2010)Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20 J Clin Oncol 28 1677-354
[4]  
Győrffy B(2015)Prospective validation of a 21-gene expression assay in breast cancer N Engl J Med 373 150927220039001-5312
[5]  
Hatzis C(2016)Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 14 324-83
[6]  
Sanft T(2007)American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer J Clin Oncol 25 5287-61
[7]  
Mamounas EP(2008)Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes Eur J Cancer 44 73-519
[8]  
Tang G(2010)Lobular breast carcinoma and its variants Semin Diagn Pathol 27 49-1880
[9]  
Fisher B(2015)Comprehensive molecular portraits of invasive lobular breast cancer Cell 163 506-5372
[10]  
Sparano JA(2016)Genomic characterization of primary invasive lobular breast cancer J Clin Oncol 34 1872-291